Effexor and Bone density decreased - a phase IV clinical study of FDA data

Summary:

Bone density decreased is found among people who take Effexor, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Effexor and have Bone density decreased. It is created by eHealthMe based on reports of 88,368 people who have side effects when taking Effexor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

88,368 people reported to have side effects when taking Effexor.
Among them, 160 people (0.18%) have Bone density decreased.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 95,353 Effexor users for its effectiveness, alternative drugs and more.

What is Bone density decreased?

Bone density decreased is found to be associated with 1,759 drugs and 888 conditions by eHealthMe.

Number of Effexor and Bone density decreased reports submitted per year:

Could Effexor cause Bone density decreased?

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and have Bone density decreased?

Check whether Bone density decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Bone density decreased and when was it recovered:

Bone density decreased in Effexor

Expand to all the drugs that have ingredients of venlafaxine hydrochloride:

Bone density decreased and drugs with ingredients of venlafaxine hydrochloride (237 reports)

Alternative drugs to, pros and cons of Effexor:

Effexor (95,353 reports)

Common Effexor side effects:

Stress and anxiety: 7,143 reports
Fatigue (feeling of tiredness): 6,506 reports
Depression: 6,358 reports
Headache (pain in head): 6,064 reports
Drug ineffective: 5,736 reports
Dizziness: 5,656 reports

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Bone density decreased treatments and more:

Bone density decreased (50,433 reports)

COVID vaccines that are related to Bone density decreased:

Common drugs associated with Bone density decreased:

All the drugs that are associated with Bone density decreased:

Bone density decreased (1,759 drugs)

Common conditions associated with Bone density decreased:

Hiv infection: 30,804 reports
Osteoporosis: 3,741 reports
Rheumatoid arthritis: 916 reports
Pain: 568 reports
High blood pressure: 510 reports
Juvenile rheumatoid arthritis: 506 reports
Gastroesophageal reflux disease: 475 reports
Depression: 442 reports

All the conditions that are associated with Bone density decreased:

Bone density decreased (888 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor) and Effexor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.